The Company

Management

INRIS’ management team is highly experienced in the medical device and diagnostics industries, including specific and deep expertise in the vascular access field. They also have extensive experience in the start-up/early stage environment, and in raising financing for companies at various stages of development.

The team is:

James W. Sharpe—Chief Executive Officer—Mr. Sharpe has over 30 years experience in the life sciences industry including over 20 years in marketing, sales, and strategic planning in medical devices and medical imaging, diagnostics, reagents and chemicals with Eastman Kodak, Centocor, and Benzon Pharma A/S. Mr. Sharpe has also been CEO of a public biotech company, President of a drug discovery company, and COO of a drug delivery company. He has broad experience in development and growth of start-up businesses, including raising over $20 million for several early stage companies. He also an extensive background in business and corporate development where he has initiated, negotiated and closed distribution and co-marketing agreements, joint product development agreements, licensing agreements, and sale or acquisition of products and companies (M&A). Mr. Sharpe has a B.S. in Chemistry from Union College; and an MBA in Marketing & Finance from the University of Rochester.

Dale Siegel, Ph.D.,—President (and Founder)—Dr. Siegel has spent his entire career in biomedical industry where he has held various research management roles at Hoffmann-LaRoche, and a business development role at Praxis Biologics (now Lederle-Praxis). While at Praxis he worked directly with the CEO in the sale of the company to Lederle Laboratories. Subsequent to Praxis, he worked as a consulting research analyst and then in an investment banking role working with emerging biomedical companies. In 1995 he joined a statewide (Ohio) economic development organization as one of three regional directors where he was instrumental in starting five companies, three of which survive today. Mr. Siegel obtained his Bachelor’s degree at Bucknell University, and Ph.D. at Temple University Medical School.

John A Skolas, Chief Financial Officer—Mr. Skolas has extensive experience developing, managing and optimizing financial and legal functions in small and large companies, as well as negotiating and closing a wide range of transactions. For the UK multinational EMI Group (f/k/a THORN EMI), Mr. Skolas served as President of a shared services subsidiary that provided treasury, cash management, M&A, divestiture, tax, legal and patent licensing to EMI’s US subsidiaries in various businesses including music, retail and technology. Mr. Skolas’ work for EMI included closings on more than $1 billion in debt financings, negotiation of numerous divestitures and a wide range of other transactions. He also managed a patent licensing effort that collected more than $240 million in royalties. In recent years, Mr. Skolas established and/or revamped accounting and financial functions in life science companies, most recently serving from 2003 to 2007 as CFO and General Counsel of a NASDAQ traded drug development company. In that capacity, Mr. Skolas closed five registered direct offerings of common stock, led compliance with the newly established Sarbanes Oxley requirements, and completed numerous complex agreements for conduct of clinical trials as well as manufacturing and licensing. Mr. Skolas spent his early career as a tax specialist at Coopers & Lybrand and later as a partner in a law firm. Mr. Skolas obtained a CPA certificate from the State of Iowa in 1976. He earned an MBA from Harvard Business School in 1988 and a JD from the University of Wisconsin in 1977.

Robert L. Crane, Ph.D., Chief Scientific Officer—Dr. Crane is retired from the U.S. Air Force, where he was a Fellow of the Air Force Institute of Technology. He is the lead inventor of INRIS’s infrared imaging technology, and the principal inventor on the fundamental Crane, et. al. patent for use of nIR for imaging of subcutaneous structures. His specialties include ceramic engineering, materials science, optics and physics. He is an Adjunct Professor at The Air Force Institute of Technology, Wright State University, University of Dayton and University of California at Los Angeles. Dr. Crane was a member of the select NASA Columbia Accident Investigation Board, and is credited with a major contribution to solving the adhesion problem for heat deflecting tiles in the space shuttle program. He has also made important contributions to USAF stealth technology, and to non-invasive testing methods for assessing molecular bonding as a means of confirming air frame integrity. He is the inventor of five commercially viable technologies currently in worldwide use. He received his BS and Ph.D. from The Ohio State University.

David Cubanski, PH.D, Vice President, Engineering and Product Development—Dr. Cubanski, the founder and owner of Mosaic Engineering, Inc., an optical-engineering firm in State College, Pennsylvania, has broad experience in the design and development of optical and electronic imaging systems and instrumentation. Since receiving his Ph.D. in Electrical Engineering from the Worcester Polytechnic Institute (WPI) he has worked with numerous large and small companies for development of highly advanced imaging systems in the digital imaging and machine vision industries. He has also worked on numerous imaging-related research projects as a faculty member in the engineering departments of both WPI and the Pennsylvania State University. Dr. Cubanski's areas of expertise include optics, materials science, circuit design, digital design, and mechanical design.

Board of Directors

Samuel Kiehl, M.D.: Dr. Kiehl is Assistant Professor of Emergency Medicine at Ohio State University; Director of the Emergency Department at Riverside Methodist Hospitals, Columbus, Ohio for 18.5 years. Investor, founder and President of Olentangy Emergency Physicians, an emergency department management company that operates 11 emergency departments. Founder and CEO of PPMC, a billing and receivables management company providing services to over 1,000 physicians. Reimbursement chairman for the American College of Emergency Physicians, Ohio Chapter, working with insurance companies, Medicare and Medicaid to establish coding and reimbursement policy for Emergency physicians; medical advisor for several Emergency squads.

Michael D. Schlesinger: Mr. Schlesinger has over twenty years experience in the investment banking business, primarily with Shearson Lehman, Paine Webber and Dean Witter where he specialized in public and private offerings, corporate strategic advisory services and mergers & acquisitions. In addition to being an investor in INRIS, he has co-founded a venture capital fund and a financial services firm and has raised capital for and invested in several venture stage companies. In the course of his career, he has been involved with healthcare companies in the areas of medical devices, specialized healthcare services and generic pharmaceuticals. Mr. Schlesinger holds an AB from Harvard College and an MBA from Harvard Business School.

James Sharpe: see management above

Dale Siegel: see management above

Medical Advisory Board

Elliott Fishman, M.D.—Radilogist—Johns Hopkins University—Dr. Fishman, who is a Professor of Radiology and Oncology, and the Director of Diagnostic Radiology and Body CT at Johns Hopkins, was named “Top Radiologist in the Nation” by Medical Imaging magazine in 2007. Dr. Fishman is a pioneer in the development of 3-D medical imaging. He also runs a web site, http://www.ctisus.com, which has won numerous awards and is one of the largest medical web sites in the world; used by more than 50,000 medical professionals each month.

Lynn Hadaway, R.N., CRNI—Vascular Access Consultant—Ms. Hadaway is a nationally recognized vascular access expert and a widely recognized opinion leader in infusion nursing. She is a 30 year nursing veteran and vascular access “go to” nurse prior to establishing her own consulting firm. She is the founder of the Infusion Nursing Society (INS), and consults with both hospitals and industry.

Samuel Kiehl, M.D.—Emergency Physician—Ohio State University—see Board of Directors